| Literature DB >> 35207000 |
Nehad Ahmed1,2, Mohamed Balaha1,3, Abdul Haseeb4, Amer Khan2.
Abstract
Antibiotic prophylaxis is used to decrease the bacterial load in the wound to assist the natural host defenses in preventing the occurrence of surgical site infections. The present study aimed to investigate trends in using antibiotic prophylaxis in the surgical ward of a governmental hospital in the Riyadh Region and included collecting data concerning the use of antibiotic prophylaxis from medical electronic records. During 2020, most of the surgical patients received systemic antibiotics (82.40%). The most prescribed antibiotics were ceftriaxone (28.44%) and metronidazole (26.36%). The study also found that most of the patients received antibiotics for seven days or for five days, and only 1.08% of the patients received antibiotics appropriately for a maximum of one day. The present study showed that there was a major problem in selecting the correct antibiotic and in the duration of its use compared with the recommendations of the surgical prophylaxis guideline that was issued by the Saudi Ministry of Health. Thus, there is an urgent need to improve the adherence to the recommendations of surgical antibiotic prophylaxis guidelines in order to reduce the occurrence of negative consequences.Entities:
Keywords: antibiotic; appropriateness; prophylaxis; surgical; usage
Year: 2022 PMID: 35207000 PMCID: PMC8872316 DOI: 10.3390/healthcare10020387
Source DB: PubMed Journal: Healthcare (Basel) ISSN: 2227-9032
Figure 1The number of patients included in this study.
Number of different antibiotics prescribed in the surgical ward.
| Antibiotic | Number | Percentage |
|---|---|---|
| Ceftriaxone | 397 | 28.44 |
| Metronidazole | 368 | 26.36 |
| Piperacillin/Tazobactam | 90 | 6.45 |
| Cefazolin | 71 | 5.09 |
| Gentamicin | 69 | 4.94 |
| Amoxicillin/Clavulanic acid | 68 | 4.87 |
| Meropenem | 67 | 4.80 |
| Ciprofloxacin | 59 | 4.23 |
| Imipenem/Cilastatin | 46 | 3.30 |
| Cefuroxime | 35 | 2.50 |
| Linezolid | 27 | 1.93 |
| Vancomycin | 26 | 1.86 |
| Azithromycin | 20 | 1.43 |
| Amoxicillin | 12 | 0.86 |
| Ceftazidime | 10 | 0.72 |
| Clindamycin | 10 | 0.72 |
| Doxycycline | 7 | 0.50 |
| Cefotaxime | 4 | 0.29 |
| Tigecycline | 4 | 0.29 |
| Amikacin | 1 | 0.07 |
| Cefepime | 1 | 0.07 |
| Colistin | 1 | 0.07 |
| Clarithromycin | 1 | 0.07 |
| Moxifloxacin | 1 | 0.07 |
| Ceftazidime/Avibactam | 1 | 0.07 |
| Total number of antibiotics | 1396 | 100 |
The personal data of the patients who received antibiotics in the surgical ward.
| Variable | Category | Number | Percentage |
|---|---|---|---|
| Gender | Male | 461 | 61.14% |
| Female | 293 | 38.86% | |
| Age | <10 | 38 | 5.04% |
| 10–19 | 44 | 5.83% | |
| 20–29 | 153 | 20.29% | |
| 30–39 | 172 | 22.81% | |
| 40–49 | 147 | 19.50% | |
| 50–59 | 101 | 13.40% | |
| >59 | 99 | 13.13% |
The prescribed dosage forms of antibiotics in the surgical ward.
| Antibiotic | Capsule or Tablet | Syrup or Suspension | Vial or Ampule |
|---|---|---|---|
| Ceftriaxone | 0 | 0 | 397 |
| Metronidazole | 35 | 1 | 332 |
| Piperacillin/Tazobactam | 0 | 0 | 90 |
| Cefazolin | 0 | 0 | 71 |
| Gentamicin | 0 | 0 | 69 |
| Amoxicillin/Clavulanic acid | 22 | 6 | 40 |
| Meropenem | 0 | 0 | 67 |
| Ciprofloxacin | 24 | 0 | 35 |
| Imipenem/Cilastatin | 0 | 0 | 46 |
| Cefuroxime | 1 | 0 | 34 |
| Linezolid | 0 | 0 | 27 |
| Vancomycin | 0 | 0 | 26 |
| Azithromycin | 17 | 3 | 0 |
| Amoxicillin | 8 | 4 | 0 |
| Ceftazidime | 0 | 0 | 10 |
| Clindamycin | 0 | 0 | 10 |
| Doxycycline | 7 | 0 | 0 |
| Cefotaxime | 0 | 0 | 4 |
| Tigecycline | 0 | 0 | 4 |
| Amikacin | 0 | 0 | 1 |
| Cefepime | 0 | 0 | 1 |
| Colistin | 0 | 0 | 1 |
| Clarithromycin | 1 | 0 | 0 |
| Moxifloxacin | 1 | 0 | 0 |
| Ceftazidime/Avibactam | 0 | 0 | 1 |
| Total | 116 (8.31%) | 14 (1.00%) | 1266 (90.69%) |
The duration of the use of antibiotics in the surgical ward.
| Antibiotic | 1 Day | 2 Days | 3 Days | 4 Days | 5 Days | 6 Days | 7 Days |
|---|---|---|---|---|---|---|---|
| Ceftriaxone | 3 | 14 | 25 | 3 | 57 | 0 | 295 |
| Metronidazole | 0 | 1 | 10 | 4 | 104 | 1 | 248 |
| Piperacillin/Tazobactam | 0 | 0 | 1 | 0 | 8 | 0 | 81 |
| Cefazolin | 6 | 3 | 27 | 0 | 21 | 1 | 13 |
| Gentamicin | 1 | 1 | 22 | 0 | 18 | 0 | 27 |
| Amoxicillin/Clavulanic acid | 3 | 1 | 6 | 1 | 10 | 1 | 46 |
| Meropenem | 0 | 0 | 0 | 0 | 0 | 3 | 64 |
| Ciprofloxacin | 0 | 0 | 3 | 0 | 12 | 0 | 44 |
| Imipenem/Cilastatin | 0 | 0 | 0 | 0 | 2 | 0 | 44 |
| Cefuroxime | 0 | 0 | 1 | 0 | 12 | 0 | 22 |
| Linezolid | 0 | 0 | 1 | 0 | 4 | 0 | 22 |
| Vancomycin | 0 | 0 | 1 | 0 | 1 | 0 | 24 |
| Azithromycin | 0 | 1 | 7 | 0 | 6 | 2 | 4 |
| Amoxicillin | 0 | 0 | 0 | 0 | 5 | 0 | 7 |
| Ceftazidime | 0 | 0 | 0 | 0 | 2 | 0 | 8 |
| Clindamycin | 0 | 0 | 2 | 0 | 4 | 0 | 4 |
| Doxycycline | 0 | 0 | 0 | 0 | 0 | 0 | 7 |
| Cefotaxime | 1 | 0 | 0 | 0 | 2 | 0 | 1 |
| Tigecycline | 1 | 0 | 0 | 0 | 0 | 0 | 3 |
| Amikacin | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Cefepime | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Colistin | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Clarithromycin | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Moxifloxacin | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Ceftazidime/Avibactam | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Total | 15 (1.08%) | 21 (1.51%) | 106 (7.59%) | 8 (0.57%) | 268 (19.20%) | 8 (0.57%) | 970 (69.48%) |